Cost-effectiveness analysis of different dipeptidyl-peptidase 4 inhibitor drugs for treatment of type 2 diabetes mellitus.

Autor: Cazarim MS; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil. Electronic address: mscazarim@usp.br., da Cruz-Cazarim ELC; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil. Electronic address: estaelcruz@fcfrp.usp.br., Baldoni AO; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: andrebaldoni@ufsj.edu.br., Dos Santos TBE; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: enesthais@gmail.com., de Souza PG; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: paula.gsouza@hotmail.com., Silva IA; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: ingrid-almeida@hotmail.com., Rodrigues RNR; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: robertaniriam@gmail.com., Maia ACFC; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: aldinhamaia@hotmail.com., Pereira LRL; Faculty of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Brazil. Electronic address: lpereira@fcfrp.usp.br., Sanches C; Federal University of São João Del-Rei (UFSJ), Brazil. Electronic address: csanches@ufsj.edu.br.

Publikováno v: Diabetes & metabolic syndrome [Diabetes Metab Syndr] 2017 Dec; Vol. 11 Suppl 2, pp. S859-S865. Date of Electronic Publication: 2017 Jul 03.